Acrivon Therapeutics, Inc. Common Stock (ACRV) financial statements and ratios from SEC XBRL: revenue $7.00M (TTM), net margin -862.7%. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $7.00M |
| Net Margin | -862.7% |
| Price / Book | 1.09 |
| FCF Yield | -133.7% |
| Sector P/E (Healthcare) | 21.7 |
ACRV overview · ACRV earnings · ACRV KPIs · ACRV investor relations · ACRV ownership · ACRV peers · ACRV filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.